The ProParaflu+ assay joins a line of tests Prodesse sells for diagnosing and differentiating respiratory viruses.
The FDA cleared an update to the package insert for its Verigene Respiratory Virus Nucleic Acid Test to include reactivity with Influenza A in cultured clinical isolates containing 2009 H1N1 influenza virus.
Roche becomes the latest of a handful of vendors to get an EUA from the FDA to sell its 2009 H1N1 flu assay to CLIA labs.
The guidance document is intended to help manufacturers develop diagnostic tests for the 2009 H1N1 influenza virus, and provides information regarding filing for Emergency Use Authorization.
The FDA cleared the firm's microarray-based multiplex platform and a rheumatoid arthritis test that runs on the system.
The FDA cleared analytical reactivity information to be added to a package insert for the firm's RAMP Influenza A/B Assay.
The newest authorization allows testing on 3M's molecular diagnostic system.
Nanosphere received FDA clearance for its influenza and respiratory virus test to run on its new Verigene SP System.
23andMe and Airbnb have partnered to offer "heritage travel," according to Venture Beat.
China may include regulations protecting genes and embryos in its update of its civil code, Nature News reports.
In Nature this week: exome sequence analysis of individuals with type 2 diabetes, genomic prediction of maize yield across environments, and more.
NPR reports on efforts to engineer bacteriophages to destroy antibiotic-resistance bacteria.